Skip to content
OpenCapital
Get started

Organon OGN Shares (Diluted)

Shares (Diluted) at other companies

Pfizer logo
PfizerPFE
5.7B+0.4%
Amgen logo
AmgenAMGN
544M+0.6%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
195M-2.8%
Biogen logo
BiogenBIIB
148.4M+1.2%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
328.9M+1.5%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's shares (diluted)?
Organon (OGN) reported shares (diluted) of 262.9M in Q1 2026.
How has Organon's shares (diluted) changed year-over-year?
Organon's shares (diluted) increased by 0.7% year-over-year, from 261M to 262.9M.
What is the long-term trend for Organon's shares (diluted)?
Over 4 years (2021 to 2025), Organon's shares (diluted) has grown at a 0.7% compound annual growth rate (CAGR), from 1B to 1B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.